QSBS US founders abroad — TaxYork US & UK expat tax specialists

Introduction

QSBS US founders abroad hold one of the most generous tax breaks in the American code, yet living overseas can quietly destroy it. Furthermore, Section 1202 can wipe out federal tax on millions of pounds of exit gain, but only when every condition is met. A founder who moves to London before selling may keep the US exclusion and still face a full British tax bill. Therefore, the interaction between two systems decides whether the relief survives.

This guide explains how the Section 1202 exclusion works, what the 2025 reforms changed, and where the benefit collapses for Americans abroad. Additionally, we share a real client scenario with precise numbers. Consequently, by the end you will understand the specific steps that protect your gain across both sides of the Atlantic.

https://www.law.cornell.edu/uscode/text/26/1202

Why QSBS US Founders Abroad Face a Unique Challenge

These founders operate under two tax authorities at once, and each treats the same share sale differently. Moreover, the United States taxes its citizens on worldwide income regardless of where they live, so your American filing never pauses. Meanwhile, the United Kingdom taxes residents on their global gains once the residence tests bite. Consequently, a single exit can attract attention from both the Internal Revenue Service and HM Revenue and Customs.

The Section 1202 exclusion is a purely American benefit. Specifically, it removes qualifying gain from US federal tax, yet it carries no weight with HMRC. Therefore, a founder who relies on the exclusion without cross-border planning may still owe substantial British capital gains tax.

What QSBS US Founders Abroad Need to Know First

Founders in this position must understand that Section 1202 rewards long-term ownership of small company shares. Consequently, qualifying gain on a sale can escape federal income tax entirely. For founders holding early equity, that exclusion is often the single largest tax saving of their careers.

The relief applies only to stock in a US C-corporation that meets strict tests. Furthermore, the shares must be acquired at original issue, not bought from another shareholder. As a result, founders and early employees are the classic beneficiaries.

The Section 1202 Exclusion in Brief

Section 1202 lets eligible shareholders exclude gain on qualified small business stock from federal tax. Importantly, the exclusion is capped at the greater of a fixed dollar figure or ten times the basis in the shares. Therefore, even a modest founder investment can shelter an enormous exit.

The gain must come from stock held for a minimum period, and the company must satisfy an active business test. Additionally, the corporation's gross assets must stay below a statutory ceiling when the stock is issued. Consequently, the relief targets genuine start-ups rather than mature enterprises.

https://www.investopedia.com/terms/s/section-1202.asp

The 2025 Rules: Bigger Caps and Tiered Holding Periods

The 2025 US tax legislation reshaped Section 1202 for stock issued after 4 July 2025. Notably, lawmakers introduced a tiered exclusion, raised the lifetime cap, and lifted the company size limit. Therefore, the relief became both larger and easier to access for new issuances.

Stock acquired before 5 July 2025 keeps the older rules. Consequently, founders now navigate two parallel regimes, and the date of issuance determines which applies. For that reason, precise record-keeping around each equity grant is essential.

The New Tiered Gain Exclusion

Under the old rules, a founder needed a five-year hold to reach full exclusion. However, the new tiered system rewards shorter holds for post-July 2025 stock. Specifically, a three-year hold now delivers a fifty per cent exclusion, a four-year hold seventy-five per cent, and a five-year hold the full hundred per cent.

This flexibility helps founders who exit earlier than planned. Furthermore, a partial exclusion still removes a meaningful slice of gain from federal tax. As a result, even an accelerated sale can capture real value.

Higher Caps for Stock Issued After July 2025

The lifetime per-issuer cap rose from ten million to fifteen million dollars for newer stock. Additionally, the ten-times-basis alternative remains, so large founder investments can shelter even more. Meanwhile, the company's gross assets ceiling increased from fifty million to seventy-five million dollars.

These higher limits widen the pool of qualifying companies. Consequently, more venture-backed start-ups now fit within the rules at the point of investment. Therefore, founders should confirm the asset position on each issuance date.

https://www.irs.gov/publications/p550

Where the Exclusion Breaks Down for Americans Abroad

The Section 1202 exclusion is powerful at home, yet it frays badly across borders. Above all, it protects you from US tax alone, and it offers nothing against a British charge. Therefore, residence and company structure become the two decisive factors for founders overseas.

Many founders assume the exclusion travels with them. In reality, it does not, and the gap can cost seven figures. Consequently, the cross-border position demands planning long before any sale.

The UK Does Not Recognise Section 1202

HMRC treats a share disposal by a UK resident as a chargeable event under British rules. Crucially, it ignores the US exclusion entirely, so the whole gain can fall within UK capital gains tax. Since 30 October 2024, the main rates stand at eighteen and twenty-four per cent for higher-value gains.

The mismatch is stark and often surprising. Because the US tax is nil after exclusion, there is no American tax to credit against the UK charge. Consequently, a founder can face full British tax with no offsetting relief. Therefore, timing the sale relative to UK residence is critical.

The C-Corporation Requirement

Section 1202 applies only to stock in a domestic US C-corporation. However, founders who build their company as a UK limited company receive no QSBS benefit at all. Therefore, the choice of entity at incorporation shapes eligibility for years.

Some founders convert or restructure before an exit, hoping to capture the relief late. Nevertheless, the original issuance and holding rules usually defeat such last-minute moves. As a result, early structuring advice is far more valuable than a rushed reorganisation.

https://www.gov.uk/capital-gains-tax

https://www.gov.uk/government/organisations/hm-revenue-customs

Qualifying Rules Every Founder Must Meet

Section 1202 sets several tests, and failing any one can forfeit the exclusion. Specifically, the rules govern how you acquired the stock, how long you held it, and what the company does. Therefore, founders should document compliance from the first grant onward.

The tests reward genuine operating businesses. Moreover, they exclude many professional service firms and passive holding structures. Consequently, the relief is narrower than many founders assume.

Original Issuance and Holding Period

The stock must be acquired at original issue in exchange for money, property or services. Furthermore, secondary purchases from another shareholder never qualify. As a result, buying shares from a departing co-founder will not earn the exclusion.

The holding period runs from the issuance date to the sale. Additionally, the tiered rules for newer stock reward each additional year of ownership. Therefore, patience directly increases the excluded portion of the gain.

The Active Business and Gross Assets Tests

At least eighty per cent of the company's assets must be used in an active qualified trade. Notably, certain sectors, including many finance, law and hospitality businesses, are excluded by statute. Consequently, technology and product companies dominate the pool of eligible issuers.

The corporation's aggregate gross assets must sit below the ceiling when the stock is issued. Moreover, that ceiling rose to seventy-five million dollars for post-July 2025 issuances. Therefore, capturing the asset figure on each issuance date protects your claim.

https://www.investopedia.com/terms/q/qsbs.asp

https://www.icaew.com/insights/viewpoint-article/2024/feb-2024/tax-guide-for-expats

Planning Around the Cross-Border Gap

The core problem is simple to state and hard to solve. Because the US exclusion means nothing to HMRC, the sale's timing against your UK residence drives the outcome. Therefore, coordinated planning can save far more than reactive filing.

Founders enjoy several levers, and each depends on individual facts. Specifically, residence timing, temporary non-residence rules and state exposure all shape the final bill. Consequently, modelling every option before a sale is essential.

Timing Residence and Sale

Selling while still a US tax resident and before UK residence begins can preserve the full benefit. However, the UK statutory residence test is intricate, and day counts matter. Therefore, a founder planning an exit and a move should sequence the two events with care.

For some, disposing of shares before departure removes the UK charge entirely. Additionally, a clean break from US state residency can prevent a state tax surprise. Consequently, the calendar around a relocation deserves professional attention.

Temporary Non-Residence and State Tax

The UK temporary non-residence rules can claw back gains realised during a short absence. Specifically, a founder who leaves, sells, and returns within roughly five years may still face UK tax. Therefore, a brief move abroad rarely defeats a British charge on its own.

US state tax adds another layer for founders with lingering ties. Notably, states such as California pursue former residents aggressively on large gains. Consequently, severing state residency cleanly before a sale can protect meaningful value.

https://www.gov.uk/tax-foreign-income

https://www.state.gov/citizenship/american-citizens-abroad/

A Real Client Scenario: The $12 Million Exit

Consider a client we advised, a US founder who built a software company as a Delaware C-corporation. He held founder stock issued in 2019 with a basis of just $30,000, and a buyer offered $12 million for his shares. However, he had accepted a role in London and expected to become UK resident within months.

We reviewed his position immediately. Because his stock predated July 2025, the older rules applied, and his gain qualified for a full federal exclusion under Section 1202. Consequently, his US tax on the $12 million gain fell to zero, since ten times his basis and the dollar cap comfortably covered the sum.

The UK exposure was the real risk. Specifically, had he completed the sale after becoming UK resident, HMRC could have taxed the entire gain at twenty-four per cent, roughly £2.3 million. Therefore, we structured the disposal to complete before his UK residence began and before he set foot in Britain for work. Additionally, we confirmed he held no lingering California residency that could trigger a state charge. As a result, he preserved the full exclusion on both sides and paid neither US nor UK tax on the exit.

How TaxYork Can Help

TaxYork advises US founders and executives on cross-border exits with substantial value at stake. Specifically, we confirm Section 1202 eligibility, model the UK charge, and sequence residence and sale to protect your gain. Consequently, you receive a single strategy that satisfies both tax authorities.

Our team handles the entity analysis, the holding period review, and the residence planning that underpins a clean exit. Moreover, we integrate QSBS planning with your wider estate, investment and relocation position. Therefore, nothing is optimised in isolation.

https://www.taxyork.com

https://www.taxyork.com/insights/uk-capital-gains-us-citizens

We also guide founders through the broader tax consequences of an international move. For instance, our specialists coordinate an exit alongside your relocation checklist.

https://www.taxyork.com/insights/uk-relocation-us-expat-tax-checklist

Conclusion

QSBS US founders abroad hold a remarkable federal tax break that can vanish once they cross the Atlantic. However, the Section 1202 exclusion protects you only from US tax, and HMRC ignores it completely. Furthermore, the C-corporation requirement, the holding period and the residence tests each shape whether the relief survives. Therefore, timing and expert coordination separate a tax-free exit from a seven-figure bill.

The rewards justify careful preparation. Ultimately, a well-sequenced sale can move millions into your hands free of tax on both sides. Consequently, founders should review their QSBS position long before any exit and act while the planning windows remain open. To protect your gain across two systems, speak to a specialist before you sign a deal.

https://www.aicpa.org/intlacc

https://www.moneyhelper.org.uk/en

Contact Us

TaxYork helps US founders and business owners abroad plan Section 1202 exits with confidence and precision. To discuss your position, email hello@taxyork.com or call 020 3488 8606. Additionally, you can reach our team through the website below for a confidential consultation.

https://www.taxyork.com/contact

https://www.ciot.org.uk/tax-guidance

Disclaimer

This article provides general information about the taxation of qualified small business stock for US citizens connected to the United Kingdom and does not constitute personal tax, legal or financial advice. Tax rules, thresholds and treaty interpretations change and depend on individual circumstances. Furthermore, TaxYork accepts no liability for action taken solely on the basis of this content. Therefore, you should obtain professional advice tailored to your situation before making any decision. Contact TaxYork at hello@taxyork.com or 020 3488 8606 for guidance specific to your position.

Frequently Asked Questions

QSBS is qualified small business stock in a US C-corporation that can qualify for the Section 1202 gain exclusion. For QSBS US founders abroad, the relief can remove millions of dollars of exit gain from US federal tax. However, it offers no protection against UK capital gains tax, so cross-border planning is essential.

No, HMRC does not recognise Section 1202 and treats a share sale by a UK resident as a chargeable event. Consequently, the whole gain can fall within UK capital gains tax at up to twenty-four per cent. Furthermore, because the US tax is nil after exclusion, there is no American tax to credit against the UK charge.

For stock issued after 4 July 2025, a tiered exclusion now grants fifty per cent relief at three years, seventy-five per cent at four years, and full relief at five years. Additionally, the lifetime cap rose to fifteen million dollars and the gross assets ceiling to seventy-five million. However, earlier stock keeps the original five-year, ten-million-dollar rules.

No, Section 1202 applies only to stock in a domestic US C-corporation. Therefore, founders who build their business as a UK limited company receive no QSBS benefit. Consequently, the choice of entity at incorporation is critical for anyone wanting the relief later.

Selling while still a US resident and before UK residence begins can preserve the full exclusion without a UK charge. However, the statutory residence test and temporary non-residence rules are complex and fact-specific. Therefore, you should sequence any exit and relocation with professional advice.

Yes, if you retain residency ties to a US state, that state may tax the gain even when Section 1202 removes the federal charge. Notably, states such as California pursue former residents aggressively. Consequently, severing state residency cleanly before a sale can protect significant value.

Get in Touch

Ready to get
your US taxes
sorted?

Whether you need help with IRS Streamlined filings, annual US tax returns, or cross-border tax planning — our team is here for you.

View Contact Details

Send us a message